These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37664917)
21. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis. Pang R; Yang S Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128 [TBL] [Abstract][Full Text] [Related]
22. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma. Chen X; Jin J; Zheng L; Sheng Y; Sun J J BUON; 2021; 26(1):259-265. PubMed ID: 33721460 [TBL] [Abstract][Full Text] [Related]
23. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways. Jiang HC; Chen XR; Sun HF; Nie YW Hum Cell; 2020 Jan; 33(1):175-184. PubMed ID: 31782107 [TBL] [Abstract][Full Text] [Related]
25. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition. Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658 [TBL] [Abstract][Full Text] [Related]
26. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway. Chen C; Shen Z Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453 [TBL] [Abstract][Full Text] [Related]
27. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400 [TBL] [Abstract][Full Text] [Related]
28. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis. Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551 [TBL] [Abstract][Full Text] [Related]
29. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer. Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198 [TBL] [Abstract][Full Text] [Related]
30. Roles of Myc-associated zinc finger protein in malignant tumors. Zheng C; Wu H; Jin S; Li D; Tan S; Zhu X Asia Pac J Clin Oncol; 2022 Dec; 18(6):506-514. PubMed ID: 35098656 [TBL] [Abstract][Full Text] [Related]
31. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer. Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843 [TBL] [Abstract][Full Text] [Related]
32. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN. Guo K; Wang J; Shu L; Zhou G Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-29b-3p Inhibits the Migration and Invasion of Gastric Cancer Cells by Regulating the Autophagy-Associated Protein MAZ. Zhao X; Ye N; Feng X; Ju H; Liu R; Lu W Onco Targets Ther; 2021; 14():3239-3249. PubMed ID: 34040389 [TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma]. Huang DH; Jin L; Xie WW; Lin Q; Chen X Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811 [No Abstract] [Full Text] [Related]
35. High expression of COL8A1 predicts poor prognosis and promotes EMT in papillary thyroid cancer. Liang W; Chen J; Li H; Zhang P; Guan H; Li Y Endocr Connect; 2024 Dec; 13(12):. PubMed ID: 39377348 [TBL] [Abstract][Full Text] [Related]
36. Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Sponziello M; Rosignolo F; Celano M; Maggisano V; Pecce V; De Rose RF; Lombardo GE; Durante C; Filetti S; Damante G; Russo D; Bulotta S Mol Cell Endocrinol; 2016 Aug; 431():123-32. PubMed ID: 27173027 [TBL] [Abstract][Full Text] [Related]
37. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2. Xia E; Bhandari A; Shen Y; Zhou X; Wang O Int J Oncol; 2018 Nov; 53(5):1927-1938. PubMed ID: 30106140 [TBL] [Abstract][Full Text] [Related]
38. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma. Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325 [TBL] [Abstract][Full Text] [Related]
39. [Expression of SQSTM1 in papillary thyroid carcinoma and its influence on invasion, migration and proliferation of papillary thyroid cancer cells]. Yu FQ; Liu CG; Ma RS; Zhang LL; Du GB; Niu DP; Yin DT Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):147-151. PubMed ID: 33455132 [No Abstract] [Full Text] [Related]
40. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma. Meng XF; Zhao LY; Chu XF Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]